$SSRM

TSX Ekes into Green by Noon

The TSX rose 21.03 points to 36,654.15 by noon, with BRP gaining 5.7% after an upgrade. SSR Mining and Barrick Mining declined. The Canadian dollar dipped to 72.25 cents. U.S. jobs data boosted Fed rate hike bets, impacting global markets.

Original reporting
Published Sep 4, 2026, 6:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 4, 2026, 7:34 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
TSX Ekes into Green by Noon — source image
Decision brief

The 30-second read

$SSRMBearishMed
01

Why it matters

BRP's upgrade drives its price surge, while miners and energy stocks lag due to weaker sentiment from US jobs data.

02

Market read

The upgrade of BRP offers a short‑term buying opportunity, while broader market weakness suggests caution on miners and energy names.

03

What to watch

Potential impact of the pending Canada‑US trade deal on exporters and commodity exporters was not quantified.

Relevance 7/10Novelty 6/10Timing: today

Background

The article reports a mixed‑direction day for Canadian markets, highlighting a notable upgrade for BRP and broader sector moves.

Company-level read

Ticker impact

$SSRMBearishMedium confidence
Context

SSR Mining fell 1.6% to $52.77 amid broader market weakness.

Expected impact

Likely modest further downside if sector stays weak.

Evidence & confidence

Move is reactionary, not driven by company‑specific news.

$ABXBearishMedium confidence
Context

Barrick Mining dropped 58 cents to $62.38.

Expected impact

Potential modest further decline if gold prices stay soft.

Evidence & confidence

Movement mirrors sector trend, not a company‑specific event.

Market effects

Consumer discretionary and industrials showed strength, while materials and energy lagged.

Canadian equities rose modestly; US markets slipped on stronger US jobs data.

Higher‑than‑expected US payrolls increased expectations of a Fed rate hike, influencing global risk sentiment.

Counterpoint

The upgrade to BRP may be premature if underlying sales do not meet expectations; a pullback could follow.

Key entities

  • National Bank of Canada

    Provided the upgrade to BRP.

  • Federal Reserve

    Higher‑than‑expected US jobs data fuels expectations of a rate hike.

Related articles

$GOLDHighAI 8/10

Stocks Stumble to Begin Friday Session

Canada's TSX opened lower on Friday after strong U.S. jobs data raised Fed rate hike expectations. The index fell 102.51 points to 36,530.61. Mining stocks like Discovery, SSR, and Barrick declined, while BRP gained after an upgrade. U.S. markets also dropped, with the Dow, S&P 500, and Nasdaq falling. Non-farm payrolls grew 162,000 in August, exceeding expectations.

$ABXMed

Abacus Global Management affirms FY26 EPS guidance above estimates

Abacus Global Management (NYSE: ABX) reaffirmed its FY26 adjusted EPS guidance of $1.00 to $1.05, exceeding the analyst estimate of $0.99. The company will report Q2 2026 results on August 6, 2026, with a conference call scheduled for the same day. Abacus specializes in alternative asset management and data-driven financial solutions.

$ABXHigh

Abacus Q2 Revenue Rises 30%, Adjusted Net Income Beats Guidance – Minichart

Abacus Global Management (NYSE: ABX) reported Q2 2026 revenue of $73.0M, up 30% YoY. Adjusted net income exceeded guidance at $27.1M. Adjusted EBITDA rose 27% to $39.9M, maintaining a 55% margin. The company deployed $200M in capital, up 62% YoY, and raised its quarterly target to $150M-$175M. It also changed its valuation methodology to a market-based approach. Asset management raised over $1B in the last year, with annualized distributions reaching 10%.

$ABXMed

Daily Special: Dimerix, Astral Resources, Midas Minerals, ABx Group, OncoSil Medical

Australian shares fell at midday, with the S&P/ASX 200 down 0.28% to 9,089.40. Sector weakness was led by consumer discretionary, while banks and tech also declined. In small caps, Dimerix gained full US IND control for DMX-652, Astral expanded Theia Deeps drilling, Midas extended Spaatzu copper-silver results, ABx advanced Sunrise approvals, and OncoSil received US FDA approval.